1175528-91-2 Usage
Pyrrolidine derivative
A derivative of pyrrolidine This means that the compound is based on the pyrrolidine structure, which is a five-membered ring with one nitrogen atom and four carbon atoms.
Fluorine and bromine substituents
Fluorine on carbon 3 and bromine on carbon 4 of the phenyl ring These are the halogen atoms attached to the phenyl ring, which can influence the compound's reactivity, polarity, and other properties.
Pharmaceutical and agrochemical intermediate
Commonly used in the synthesis of pharmaceuticals and agrochemicals This indicates that 2-(4-bromo-3-fluorophenyl)pyrrolidine is a building block or precursor in the production of various drugs and pesticides.
Potential medical applications
Studied for its potential use in the treatment of various medical conditions, including neurological disorders This suggests that the compound may have therapeutic effects or be a component of drugs that target specific health issues, particularly those related to the nervous system.
Context-dependent properties and uses
Specific properties and uses may vary depending on the context of its application and the specific research or development goals This means that the compound's effectiveness and purpose can change based on the particular situation or the intended outcome of a study or project.
Check Digit Verification of cas no
The CAS Registry Mumber 1175528-91-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,7,5,5,2 and 8 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1175528-91:
(9*1)+(8*1)+(7*7)+(6*5)+(5*5)+(4*2)+(3*8)+(2*9)+(1*1)=172
172 % 10 = 2
So 1175528-91-2 is a valid CAS Registry Number.
1175528-91-2Relevant articles and documents
Radioactive iodine marked Larotrectinib compound, and preparation method and application thereof
-
, (2019/04/26)
The invention relates to a radioactive iodine marked Larotrectinib compound, and a preparation method and application thereof. The provided compounds comprise the radioactive iodine marked Larotrectinib compound with the following structural formula and a
